Barbara Giordani
Research Subjects
Barbara Giordani has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Savi
Department of Public Health and Infectious Diseases, “Sapienza” University of Rome, 00185, Rome, Italy
2 shared publications A. Amato
Lega Italiana Fibrosi Cistica ONLUS- LIFC, Rome, Italy
1 shared publicationAdriana Eramo
Department of Oncology and Molecular Medicine, Italian Institute of Health, Rome, Italy
1 shared publicationAdriano Angioni
UOC Laboratorio Genetica Medica, Ospedale Pediatrico “Bambino Gesù”,Rome,Italy
1 shared publicationAlberto Battezzati
ICANS, Università degli Studi di Milano, Milan, Italy
1 shared publication- Alessandra Coiana
Dipartimento di Sanità Pubblica, Medicina Clinica e Molecolare, Unità di Ricerca di Scienze Biomediche e Biotecnologie, Università degli Studi di Cagliari, via Edward Jenner s/n, 09121 Cagliari, Italy
1 shared publication
Latest Publications
- Open Access
- 30 October 2020
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 20 (1) , 1-9
New strategies of physical activity assessment in cystic fibrosis: a pilot study
Background: Regular physical activity (PA) is a valued part of cystic fibrosis (CF) care. Although the accelerometer, SenseWear Armband (SWA), accurately measures habitual PA in CF, it is mostly used for research purposes. For the first time, we analyzed different methods of measuring PA in daily life by the use of smartphones and other electronic devices such as smartwatch and Fitbit.Methods: Twenty-four stable adults with CF (mean age 37.5 ± 11.5SD yrs.; FEV158 ± 19% predicted, BMI 22.9 ± 3.2) were studied. Daily PA was monitored for seven consecutive days. All patients wore the accelerometer SWA and at the same time they monitored PA with the electronic device they used routinely. They were allocated into one of four arms according to their device: Smartwatch, Fitbit, Android smartphones and iOS smartphones. PA related measurements included: duration of PA, energy expenditure, number of steps.Results: There was a good agreement between SWA and Fitbit for number of steps (p = 0.605) and energy expenditure (p = 0.143). iOS smartphones were similar to SWA in monitoring the number of steps (p = 0.911). Significant differences were found between SWA and both Smartwatch and Android smartphones.Conclusions: Fitbit and iOS smartphones seem to be a valuable approach to monitor daily PA. They provide a good performance to measure step number compared to SWA.
- 30 October 2020
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 20 (1) , 1-9
Open AccessNew strategies of physical activity assessment in cystic fibrosis: a pilot study
Background: Regular physical activity (PA) is a valued part of cystic fibrosis (CF) care. Although the accelerometer, SenseWear Armband (SWA), accurately measures habitual PA in CF, it is mostly used for research purposes. For the first time, we analyzed different methods of measuring PA in daily life by the use of smartphones and other electronic devices such as smartwatch and Fitbit.Methods: Twenty-four stable adults with CF (mean age 37.5 ± 11.5SD yrs.; FEV158 ± 19% predicted, BMI 22.9 ± 3.2) were studied. Daily PA was monitored for seven consecutive days. All patients wore the accelerometer SWA and at the same time they monitored PA with the electronic device they used routinely. They were allocated into one of four arms according to their device: Smartwatch, Fitbit, Android smartphones and iOS smartphones. PA related measurements included: duration of PA, energy expenditure, number of steps.Results: There was a good agreement between SWA and Fitbit for number of steps (p = 0.605) and energy expenditure (p = 0.143). iOS smartphones were similar to SWA in monitoring the number of steps (p = 0.911). Significant differences were found between SWA and both Smartwatch and Android smartphones.Conclusions: Fitbit and iOS smartphones seem to be a valuable approach to monitor daily PA. They provide a good performance to measure step number compared to SWA.
- 1 December 2018
- Published by Elsevier in Respiratory Medicine
- Vol. 145, 200-205
A case-control study on pregnancy in Italian Cystic Fibrosis women. Data from the Italian Registry
- 1 December 2018
- Published by Elsevier in Respiratory Medicine
- Vol. 145, 200-205
A case-control study on pregnancy in Italian Cystic Fibrosis women. Data from the Italian Registry
- Open Access
- 16 January 2018
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 44 (S1) , 1-23
Abstracts from the 23rd Italian congress of Cystic Fibrosis and the 13th National congress of Cystic Fibrosis Italian Society
- 16 January 2018
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 44 (S1) , 1-23
Open AccessAbstracts from the 23rd Italian congress of Cystic Fibrosis and the 13th National congress of Cystic Fibrosis Italian Society